The Korean Journal of Pain
Condition   Expression Quick Search
When you enter More than two words, please use 쁝nd , or operation by means of putting ,(Comma Mark) between each word.
 
26(01) 3-13
Opioid Pharmacotherapy for Chronic Noncancer Pain: The American Experience
C. Richard Chapman, PhD
Pain Research Center, Department of Anesthesiology, School of Medicine, University of Utah, Salt Lake City, Utah, USA
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Chronic noncancer pain is a significant and growing public health challenge in the United States. Lacking effective alternative interventions for effective chronic noncancer pain management, many physicians have turned to opioid pharmacotherapy. Increased opioid prescribing brings not only gains in therapeutic benefit but also a higher incidence of adverse drug events including increased medication misuse and opioid related mortality. Currently the United States must confront the dual problems of widespread undertreated chronic noncancer pain and a prescription opioid abuse crisis. Withholding pain relieving drugs from patients in need is unjustifiable, yet drug diversion, abuse and adverse drug events have become major social as well as medical problems. At the heart of this crisis is the lack of definitive evidence about the risk to benefit ratio of opioid pharmacotherapy for chronic noncancer pain both on an individual case and on a population basis. This article describes the extent and severity of the American chronic noncancer pain problem and the history of opioid pharmacotherapy for chronic noncancer pain in the United States. It then discusses the concept of evidence based practice and reviews current evidence supporting opioid pharmacotherapy for chronic noncancer pain as well as adverse drug events related to opioid pharmacotherapy including misuse and abuse. Finally, it considers the conflict of providing pain relief versus protecting society and reviews steps that governmental agencies, industry and others are taking to contain and ultimately resolve the problems of excessive prescribing and conflicting priorities. (Korean J Pain 2013; 26: 3-13)
The Korean Journal of Pain 2013 Jan; 26(01) 3-13
Keyword : chronic pain, evidence-based practice, noncancer pain, opioid pharmacotherapy.
   

Copyright © 2001~2005 By The Korean Pain Society.
1705, Yangjae SK HUB Primo, 953-1 Dogok-dong, Gangnam-gu, Seoul 135-270, Korea.
Tel: +82-2-6241-7582,    Fax: +82-2-6241-8275,    E-mail: painfree@hanafos.com    Powered by INFOrang.co., Ltd